Fred Parks Insider Profile
4 Followers
Fred Parks, CEO, Director at Urologix, holds 100.00K shares in Urologix (Ticker: ULGX), holds 0.00 shares in Analogic Corp (Ticker: ALOG), holds 10.05K shares in Nuvectra (Ticker: NVTRQ).
Fred Parks's Trading History
| ALOGAnalogic Corp | Dec 15, 2014 | ― | Informative Sell | 141.93K | $0.00 | |
| NVTRQNuvectra | ― | ― | ― | $150.75 | ||
| ULGXUrologix | ― | CEO, Director | ― | $1.50K |
You May Also Like
Fred Parks insider profile FAQ
What is the percentage of profitable transactions made by Fred Parks?
The percentage of profitable transactions made by Fred Parks is 0%.
What is the average return per transaction made by Fred Parks?
The average return per transaction made by Fred Parks is -4.60%.
What stocks does Fred Parks hold?
Fred Parks holds: ULGX, ALOG, NVTRQ stocks.
What was Fred Parks's most profitable transaction?
Fred Parks’s most profitable transaction was an Informative Sell of ALOG stock on December 15, 2014. The return on the trade was -0.70%.
What is Fred Parks's role in Urologix?
Fred Parks's role in Urologix is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
